OCUP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ocuphire Pharma Inc

Watchlist Manager

Watchlist

Price: 1.13 USD -3.42% Market Closed

Market Cap: $35.7m

	Ocuphire Pharma Inc NASDAQ:OCUP	US
	APT Systems Inc OTC:APTY	US
	Dickson Concepts (International) Ltd HKEX:113	HK
	Province Resources Ltd ASX:PRL	AU
	Lectra SA PAR:LSS	FR
	Thomson Medical Group Ltd SGX:A50	SG
	Holland Colours NV AEX:HOLCO	NL
G	GreenX Metals Ltd WSE:GRX	AU
S	Societe BIC SA XMUN:BIF	FR
B	Bell Financial Group Ltd XBER:3EI	AU
	Maximus Resources Ltd ASX:MXR	AU
C	Century Global Commodities Corp TSX:CNT	HK
C	Clarus Corp NASDAQ:CLAR	US
A	ASML Holding NV NASDAQ:ASML	NL

Profitability Summary

Ocuphire Pharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-83%

Negative 3Y Average Operating Margin

-34%

Declining Operating Margin

40% > -83%

Negative Net Margin

-86%

Negative 3Y Average Net Margin

-37%

Declining Net Margin

41% > -86%

Negative Free Cash Flow Margin

-70%

Negative 3Y Average Free Cash Flow Margin

-13%

Declining Free Cash Flow Margin

Negative 3Y Average ROIC

-163%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.